Acetyldigitoxin is a cardiac glycoside derived from digitoxin or lanatoside A, used for rapid digitalization in heart failure research. It serves as a key tool for investigating Na+/K+-ATPase inhibition in both in vitro biochemical assays and in vivo models of cardiac function.